Division Updates
Discover a community where exceptional patient care, groundbreaking research, and transformative education come together to advance the future of medicine.
Discover the milestones that signified our clinical care growth in 2026.
Across 10 divisions, the Department of Medicine delivers nationally recognized subspecialty care for patients with complex diseases while expanding access to coordinated, responsive care throughout South Carolina. Our clinical innovators translate discovery into advanced treatments and meaningful improvements in patient outcomes statewide and beyond.
In FY26, Department of Medicine faculty, advanced practice providers, nurses and staff met growing demand while improving care across outpatient practices, hospitals and communities throughout South Carolina.
Our teams grew new patient volume by 15% and outpatient encounters by 11.3% over FY25, while clinical productivity increased 11.0% year-over-year. Since FY21, new patient volume has grown 63.8%, and clinical productivity has grown 62.4%.
This growth reflects a deliberate, department-wide commitment to meeting patients where they live. The department has significantly expanded its geographic reach across South Carolina since 2021, as shown in the map below, extending care into new communities from the Upstate to the Lowcountry. This expansion, paired with continued recruitment of clinical faculty and advanced practice providers across every specialty, is central to our mission of better access, better care and healthier communities statewide.
Technology sustains this growth without compromising quality or provider well-being. AI-powered in-basket tools and MyChart Direct Scheduling helped our teams manage a 10% increase in in-basket messages in FY26. Telehealth and remote patient monitoring also expanded through new rural telehospitalist coverage and programs serving federally qualified health centers and free clinics statewide, growing telehealth encounters by 32.7% over FY25 and extending MUSC expertise beyond our clinic walls.
None of this growth happens without our people. Across our ten divisions, clinical faculty and staff opened new clinics and access points, adopted new technologies, and reimagined care delivery for their patients. I am privileged to lead this dedicated team and look forward to building on this momentum in the year ahead.
Kimberly Davis, M.D., FACP
Vice Chair for Clinical Operations
Department of Medicine
The Department of Medicine has achieved substantial clinical growth over the past five years, driven by advanced clinical and research capabilities that distinguish us among academic medical centers. In FY26, the department welcomed 38 new faculty members and 45 advanced practice providers (APPs), supporting the continued expansion of our clinical footprint across the state.
From pulmonary embolism treatment to complex lung disease and scleroderma, MUSC Health continues to earn national recognition for clinical excellence, multidisciplinary collaboration, and research innovation.
The Bronchiectasis and NTM Association re-designated MUSC Health as a Bronchiectasis and NTM Care Center Network site, one of only a select few programs in the country and the only one in South Carolina, recognizing MUSC's expertise in diagnosing and treating these two chronic, complex lung conditions.
Patrick Flume, M.D., director of the MUSC NTM program, leads a multidisciplinary team that includes pulmonologists Christina Mingora, M.D., and Lauren Sullivan, M.D.; infectious disease specialists Susan Dorman, M.D., and Yorsa Alkabab, M.D.; and a broader group of advanced practice providers and support staff.
News article: https://medicine.musc.edu/content-hub/News/2026/05/25/ntm-program-redesignated
The Polycystic Kidney Disease Foundation renewed MUSC's designation as a Center of Excellence for another three years, one of only 39 such centers nationwide, recognizing the division's sustained commitment to exceptional PKD care.
multidisciplinary collaboration, and research innovation.
National recognition for pulmonary embolism care: The PERT Consortium, an international organization dedicated to improving pulmonary embolism (PE) care through multidisciplinary response teams, accredited MUSC Health as a Comprehensive PE Center of Excellence, one of only 18 institutions internationally and the only one in South Carolina to hold this distinction. Led by Denise Sese, M.D., and building on the foundational work of Thomas Todoran, M.D., MUSC's multidisciplinary team delivers the swift, coordinated care that this life-threatening condition demands.
Related news story:
https://www.musc.edu/content-hub/News/2026/02/03/musc-health-becomes-first-in-state-to-offer-balloon-angioplasty-for-ctephThe National Scleroderma Foundation designated the MUSC Scleroderma Center as a Scleroderma Research and Treatment Center, an honor held by only a select group of institutions nationwide and the only one in South Carolina, recognizing MUSC's strength in multidisciplinary care and translational research for this rare, complex autoimmune disease.
Richard Silver, M.D., leads the center's specialists across rheumatology, pulmonology, cardiology, dermatology, and gastroenterology in providing coordinated care, alongside research led by Carol Feghali-Bostwick, Ph.D., and colleagues studying fibrosis, disease progression, and potential anti-fibrotic therapies.
News article: https://medicine.musc.edu/content-hub/News/2025/03/26/scleroderma-center-recognition
MUSC Department of Medicine 2026 Annual Report
Discover a community where exceptional patient care, groundbreaking research, and transformative education come together to advance the future of medicine.
This year has been one of remarkable growth and continued excellence in medical education.
The Department of Medicine is fostering a culture where every team member feels valued, respected, and empowered to contribute.
Philanthropy transforms gratitude into progress, empowering groundbreaking research, advancing discoveries and care, and bringing hope for better outcomes to patients and families.
Learn more about the recent advances in basic, clinical and translational research.
This was a year of substantial growth and expansion.